249 related articles for article (PubMed ID: 30468982)
1. Sonographic and hysteroscopic endometrial examination in women treated with ulipristal acetate: Exploratory findings at a tertiary referral center.
Gracia M; Nonell R; Ros C; Rius M; Quintas L; Martínez-Zamora MÁ; Carmona F
Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():40-45. PubMed ID: 30468982
[TBL] [Abstract][Full Text] [Related]
2. Hysteroscopic Patterns in Women on Treatment With Ulipristal Acetate 5 mg/day: A Preliminary Study.
Bettocchi S; Baranowski WE; Doniec J; Ceci O; Resta L; Fascilla FD; Mitola PC; Tinelli R; Cicinelli E
J Minim Invasive Gynecol; 2016; 23(5):664-9. PubMed ID: 26803918
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study.
De Franciscis P; Schiattarella A; Riemma G; Labriola D; Ambrosio D; Vitale SG; Cianci A; Cucinella G; Calagna G; Colacurci N
Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):435-440. PubMed ID: 33043778
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic appearance of the endometrium after saline infusion in women presenting with PRM-associated endometrial changes, due to the use of ulipristal acetate.
Cosyns S; Dony N; Tournaye H; Polyzos NP
J Obstet Gynaecol; 2022 Oct; 42(7):2888-2892. PubMed ID: 36017902
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of Endometrial Pathologic Findings Obtained on Hysteroscopy, Transvaginal Sonography, and Gel Infusion Sonography in Women With Postmenopausal Bleeding.
Dueholm M; Hjorth IM; Secher P; Jørgensen A; Ørtoft G
J Minim Invasive Gynecol; 2015; 22(6):1036-44. PubMed ID: 26044592
[TBL] [Abstract][Full Text] [Related]
6. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.
Whitaker LH; Murray AA; Matthews R; Shaw G; Williams AR; Saunders PT; Critchley HO
Hum Reprod; 2017 Mar; 32(3):531-543. PubMed ID: 28130434
[TBL] [Abstract][Full Text] [Related]
7. Uterine surveillance of asymptomatic postmenopausal women taking tamoxifen.
Gardner FJ; Konje JC; Brown L; Khanna S; Bell SC; Taylor DJ; al-Azzawi F
Climacteric; 1998 Sep; 1(3):180-7. PubMed ID: 11907942
[TBL] [Abstract][Full Text] [Related]
8. The endometrial response to modulation of ligand-progesterone receptor pathways is reversible.
Chodankar RR; Murray A; Nicol M; Whitaker LHR; Williams ARW; Critchley HOD
Fertil Steril; 2021 Sep; 116(3):882-895. PubMed ID: 33865567
[TBL] [Abstract][Full Text] [Related]
9. Endometrial Changes in Surgical Specimens of Perimenopausal Patients Treated With Ulipristal Acetate for Uterine Leiomyomas.
Nogales FF; Crespo-Lora V; Cruz-Viruel N; Chamorro-Santos C; Bergeron C
Int J Gynecol Pathol; 2018 Nov; 37(6):575-580. PubMed ID: 28914672
[TBL] [Abstract][Full Text] [Related]
10. UPA effects on endometrium - what is the significance?
Pleş L; Sima RM; Carp D; Florescu C; Dimitriu MCT; Ionescu CA
Rom J Morphol Embryol; 2018; 59(4):1127-1132. PubMed ID: 30845294
[TBL] [Abstract][Full Text] [Related]
11. Ulipristal acetate prior to in vitro fertilization in a female patient affected by uterine fibroids: a case report.
Lo Monte G; Piva I; Graziano A; Engl B; Marci R
Eur Rev Med Pharmacol Sci; 2016; 20(2):202-7. PubMed ID: 26875885
[TBL] [Abstract][Full Text] [Related]
12. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
13. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
14. Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance?
Ferrero S; Vellone VG; Barra F; Scala C
Gynecol Obstet Invest; 2019; 84(4):313-325. PubMed ID: 30554215
[TBL] [Abstract][Full Text] [Related]
15. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
Szamatowicz M; Kotarski J
Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
[TBL] [Abstract][Full Text] [Related]
16. Endometrial changes during ulipristal acetate use: A systematic review.
De Milliano I; Van Hattum D; Ket JCF; Huirne JAF; Hehenkamp WJK
Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():56-64. PubMed ID: 28482329
[TBL] [Abstract][Full Text] [Related]
17. Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium.
Kolanska K; Varinot J; Canlorbe G; Bergeron C; Mekinian A; Capmas P; Koskas M; Daraï E; Aractingi S; Bendifallah S; Chabbert-Buffet N
Reprod Biomed Online; 2019 May; 38(5):825-834. PubMed ID: 30898512
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy.
Ferrero S; Scala C; Vellone VG; Paudice M; Vitale SG; Cianci A; Barra F
Gynecol Obstet Invest; 2020; 85(2):178-183. PubMed ID: 31940645
[TBL] [Abstract][Full Text] [Related]
19. Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report.
Bateman J; Bougie O; Singh S; Islam S
Pathol Res Pract; 2017 Jan; 213(1):79-81. PubMed ID: 27914766
[TBL] [Abstract][Full Text] [Related]
20. Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium.
Schmidt T; Breidenbach M; Nawroth F; Mallmann P; Beyer IM; Fleisch MC; Rein DT
Maturitas; 2009 Feb; 62(2):176-8. PubMed ID: 19121901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
